Multi-marker biomarker panel, adverse cardiovascular and kidney outcomes, and response to canagliflozin in the CANVAS Program

29 June 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Risk Factors and Prevention, Rehabilitation and Sports Cardiology, Cardiovascular Disease in Special Populations Diabetes and the Heart HFA Premium Access Heart Failure 2021

ESC 365 is supported by

ESC 365 is supported by